YD Bio (NASDAQ:YDES) Shares Climb 5% – Here’s Why

YD Bio Limited (NASDAQ:YDES) shares shot up 5% on Tuesday. The stock traded as high as $7.56 and last traded at $7.4650. 150,311 shares were traded during trading, an increase of 7% from the average daily volume of 140,894 shares. The stock had previously closed at $7.11.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of YD Bio to a “hold” rating in a research report on Saturday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

YD Bio Stock Up 3.6%

The firm has a fifty day moving average of $3.42 and a 200 day moving average of $4.16.

YD Bio (NASDAQ:YDES) last announced its quarterly earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $0.42 million for the quarter.

Hedge Funds Weigh In On YD Bio

A hedge fund recently raised its position in YD Bio stock. Cypress Capital Management LLC WY raised its stake in YD Bio Limited (NASDAQ:YDES) by 9.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,690 shares of the biotechnology company’s stock after purchasing an additional 3,000 shares during the period. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 as of its most recent SEC filing.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.